Nobel Laureate, Rod MacKinnon, M.D, Joins Flex Pharma (FLKS)'s Board Of Directors

2/25/2015 10:48:57 AM

Flex Pharma, Inc. (NASDAQ: FLKS), a biotechnology company that is developing innovative and proprietary treatments for nocturnal leg cramps and spasms associated with severe neuromuscular conditions, today announced that Nobel Laureate and Scientific Co-Founder, Rod MacKinnon, M.D., has joined its Board of Directors. In addition, Scientific Co-Founder, Bruce Bean, Ph.D., will join the Board as an observer based upon his significant contributions and ongoing involvement with the Company's development efforts.

Suggested Articles

Almirall and Iktos will use the latter's AI technology to design new compounds that tick multiple drug criteria boxes.

Pfizer’s 2017 spinout company SpringWorks has lost president and founder Lara Sullivan, M.D., who has moved over to Pyxis Oncology as its new chief.

In this week's EuroBiotech Report, Sanofi inks $2.5B Synthorx takeover and posts sutimlimab data, Roche shares bispecific results and more.